Samiec M et al. |
Trichostatin A-mediated epigenetic transformation of adult bone marrow-derived mesenchymal stem cells biases the in vitro developmental capability, quality, and pluripotency extent of porcine cloned embryos. |
2015 |
Biomed Res Int |
pmid:25866813
|
Hou H et al. |
Influence of intra-articular administration of trichostatin a on autologous osteochondral transplantation in a rabbit model. |
2015 |
Biomed Res Int |
pmid:25866784
|
Chan ST et al. |
Oral and intraperitoneal administration of quercetin decreased lymphocyte DNA damage and plasma lipid peroxidation induced by TSA in vivo. |
2014 |
Biomed Res Int |
pmid:24868531
|
Florea AM |
DNA methylation pyrosequencing assay is applicable for the assessment of epigenetic active environmental or clinical relevant chemicals. |
2013 |
Biomed Res Int |
pmid:24093099
|
Ilicic M et al. |
Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium. |
2017 |
Biomed Res Int |
pmid:28540297
|
Piotrowska H and Jagodzinski PP |
Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines. |
2007 |
Biomed. Pharmacother. |
pmid:17498915
|
Drzewiecka H and Jagodzinski PP |
Trichostatin A reduced phospholipase C gamma-1 transcript and protein contents in MCF-7 breast cancer cells. |
2012 |
Biomed. Pharmacother. |
pmid:22257695
|
Cheng SP et al. |
Regulation of leptin receptor expression in human papillary thyroid cancer cells. |
2012 |
Biomed. Pharmacother. |
pmid:22560341
|
Åuczak MW and JagodziÅ„ski PP |
Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells. |
2009 |
Biomed. Pharmacother. |
pmid:18602794
|
Feng W et al. |
Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells. |
2015 |
Biomed. Pharmacother. |
pmid:26349994
|
Sobolewski C et al. |
Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. |
2015 |
Biomolecules |
pmid:26343742
|
McCulloch MW et al. |
Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. |
2009 |
Bioorg. Med. Chem. |
pmid:19022675
|
Saha A et al. |
Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. |
2013 |
Bioorg. Med. Chem. |
pmid:23719282
|
Terracciano S et al. |
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. |
2010 |
Bioorg. Med. Chem. |
pmid:20381359
|
Feng T et al. |
Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). |
2013 |
Bioorg. Med. Chem. |
pmid:23820574
|
Patil V et al. |
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. |
2010 |
Bioorg. Med. Chem. |
pmid:19914074
|
Nishino N et al. |
Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. |
2008 |
Bioorg. Med. Chem. |
pmid:17900911
|
Shivashimpi GM et al. |
Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. |
2007 |
Bioorg. Med. Chem. |
pmid:17881232
|
Estiu G et al. |
On the inhibition of histone deacetylase 8. |
2010 |
Bioorg. Med. Chem. |
pmid:20472442
|
Kiyokawa S et al. |
New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. |
2010 |
Bioorg. Med. Chem. |
pmid:20452226
|